Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Income from Continuing OperationsIncome towards Parent CompanyNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Proshares Trust (ZBIO) EBT (2023 - 2025)

Historic EBT for Zenas BioPharma (ZBIO) over the last 3 years, with Q3 2025 value amounting to -$51.5 million.

  • Zenas BioPharma's EBT fell 3339.64% to -$51.5 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$194.0 million, marking a year-over-year decrease of 5020.98%. This contributed to the annual value of -$160.9 million for FY2024, which is 33700.4% down from last year.
  • According to the latest figures from Q3 2025, Zenas BioPharma's EBT is -$51.5 million, which was down 3339.64% from -$52.2 million recorded in Q2 2025.
  • In the past 5 years, Zenas BioPharma's EBT registered a high of $35.6 million during Q3 2023, and its lowest value of -$56.5 million during Q4 2024.
  • Over the past 3 years, Zenas BioPharma's median EBT value was -$38.0 million (recorded in 2024), while the average stood at -$32.0 million.
  • In the last 5 years, Zenas BioPharma's EBT tumbled by 20837.08% in 2024 and then plummeted by 2150.36% in 2025.
  • Quarter analysis of 3 years shows Zenas BioPharma's EBT stood at -$24.8 million in 2023, then plummeted by 128.15% to -$56.5 million in 2024, then rose by 8.91% to -$51.5 million in 2025.
  • Its EBT stands at -$51.5 million for Q3 2025, versus -$52.2 million for Q2 2025 and -$33.8 million for Q1 2025.